Non-steroidal anti-inflammatory drugs (NSAIDs) cause peptic ulcer disease, but whether they interact with Helicobacter pylori to promote damage is controversial. Moreover, the reported induction of apoptosis in gastric cells by H. pylori lipopolysaccharide (LPS) (10 -9 g/ml) contrasts with studies showing low immunological potency of this LPS. Therefore, the effects of LPS from H. pylori NCTC 11637 and Escherichia coli O111:B4 on apoptosis in a primary culture of guinea-pig gastric mucous cells were investigated in the presence and absence of the NSAID, ibuprofen. Cell loss was estimated by a crystal violet assay, and apoptosis determined from caspase activity and from condensation and fragmentation of nuclei. Exposure to E. coli LPS for 24 h caused cell loss and enhanced apoptotic activity at concentrations ≥ 10 -9 g/ml, but similar effects were only obtained with H. pylori LPS at concentrations ≥ 10 -6 g/ml. Although ibuprofen (250 µM) caused cell loss and apoptosis, addition of either E. coli or H. pylori LPSs further enhanced these effects. In conclusion, LPS and ibuprofen interact to enhance gastric cell loss and apoptosis. In such interactions, E. coli LPS is more potent than that of H. pylori. The low potency of H. pylori LPS may contribute to a chronic low-grade gastritis that can be enhanced by the use of NSAIDs.
INTRODUCTION
Helicobacter pylori is a Gram-negative bacterium that infects human gastric mucosa causing gastritis that can lead to peptic ulcer disease, gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. H. pylori increases apoptosis in the human stomach, 1 and in human adenocarcinoma cell lines. 2, 3 Enhancement of apoptosis may be the stimulus for a hyper-proliferative response to H. pylori 4 and could contribute to the development of gastric cancer and ulcer.
Apoptosis is a form of cell death in which proteolytic enzymes called caspases are activated and in which specific cleavage and condensation of DNA occurs. 5 Lipopolysaccharide (LPS) from H. pylori causes apoptosis when administered into the rat stomach, 6 but also exerts a cytotoxic effect in the rat duodenum when administered intravenously. 7 Intravenous administration of LPS from Escherichia coli has been shown to induce apoptosis in the rat stomach, specifically in mucous epithelial cells. 8 On the other hand, LPS from H. pylori, but not E. coli, has been reported to stimulate DNA synthesis by rat enterochromaffin-like cells in the presence of gastrin. 9 Use of the semi-quantitative 'DNA ladder' technique to assess apoptosis suggested that gastric epithelial cells were extremely sensitive to LPS from H. pylori with 10 -9 g/ml of LPS from the type strain (NCTC 11637) promoting apoptosis as did a similar concentration of LPS from E. coli. 10 Activation of Toll-like receptor-4 (TLR-4) by LPS also induced superoxide production in gastric epithelial cells with H. pylori LPS in one study 11 being more, and in another 12 slightly less, potent than that from E coli. Kawahara et al. 12 mention unpublished data showing that H. pylori LPS at a concentration of 1.9 µg/ml was unable to enhance superoxide production in murine peritoneal macrophages primed with phorbol 12-myristate-13-acetate. No comparison with the effect of E. coli LPS on macrophages was given, but this result contrasts with the enhancement of superoxide production in gastric cells by 19 ng/ml H. pylori LPS. 12 The high potency of LPS from H. pylori on gastric cells, and the lack of a difference from E. coli LPS, is not what might have been expected from a wide range of studies [13] [14] [15] [16] [17] that have shown a low immunological potency of H. pylori LPS compared with enterobacterial LPS. Definition of the interaction of LPS, from a major gastric pathogen, with gastric surface cells is clearly of considerable importance; therefore, the first aim of this work was to investigate further the actions of LPS on gastric surface cells.
Non-steroidal anti-inflammatory drugs (NSAIDs) also induce apoptosis in the stomach 18, 19 and in primary cultures of guinea-pig gastric mucous cells. [20] [21] [22] The extent to which NSAIDs and H. pylori interact to cause peptic ulcer disease is controversial. Thus, eradication of H. pylori in individuals already using NSAIDs does not affect the incidence of peptic ulcers over the following 6 months, 23 whereas eradicating H. pylori before starting patients on NSAIDs significantly reduces the subsequent occurrence of peptic ulcers. 24 A recent meta-analysis concluded that H. pylori infection increased the risk of peptic ulcer disease in NSAID takers 3.5-fold. 25 Thus, the second aim of the present work was to explore potential interactions between the NSAID, ibuprofen, and LPS on apoptosis at the level of the gastric mucous epithelial cell. Condensation and fragmentation of nuclei as well as caspase activities were used to assess apoptotic activity. In order to estimate the aggregate consequences of changes in apoptotic activity over 24 h, a crystal violet assay was employed to determine changes in cell number, and an assay of DNA synthesis was used to assess any contribution from changes in cell proliferation.
MATERIALS AND METHODS

Animals
Male Dunkin-Hartley guinea-pigs of 200-300 g body weight were obtained from Charles River (Margate, Kent, UK) and were fed on SDS Economy guinea-pig diet supplied by Lillico (Betchworth, Surrey, UK).
Materials
RPMI 1640 medium, fetal calf serum, antibiotics and amphotericin B were from Life Technologies (Paisley UK). Pronase E (70,000 PU units/g) was purchased from Merck (Poole, UK). [ 3 H]-Thymidine was obtained from Amersham Pharmacia (Little Chalfont, UK). The LPS from E. coli strain O111:B4 (L4391, Sigma; Poole, UK) was prepared by phenol-water extraction and purified by gel filtration chromatography. LPS from the H. pylori type strain (NCTC 11637; VacA-positive and CagA-positive) was prepared from biomass grown in brain-heart infusion containing 2% fetal calf serum to ensure expression of high-molecular-weight LPS. 26 This LPS was extracted, after pretreatment of bacteria with pronase E, using the hot phenol-water technique and, subsequently, was purified by treatments with RNase A, DNase II and proteinase K (all from Sigma), and by ultracentrifugation at 100,000 g at 4°C for 18 h. 27 LPS from the E. coli clinical isolate AM1 (serotyped as O:55), which was isolated from a patient with severe diarrhoeal disease (AP Moran, unpublished results), was prepared in a similar manner. Free lipid A was isolated from the H. pylori LPS after mild acid hydrolysis using 0.1 M sodium acetate buffer, pH 4.4 and centrifugation as described previously. 28 All other reagents were from Sigma.
Isolation and culture of gastric mucous cells
The method used has been described in detail previously. 29 Briefly, gastric mucosa was minced with fine scissors, incubated with 45 ml of RPMI 1640 containing 2 g/l bovine serum albumin (isolation medium) and 0.5 mg/ml pronase E for 20 min at 37°C; after centrifugation, it was incubated with 45 ml of isolation medium containing 0.4 mg/ml collagenase for 20 min. Cells were filtered through 150 µm nylon mesh, washed in culture medium (RPMI 1640 containing 10% fetal calf serum, 100 U/ml penicillin, 100 µg/ml streptomycin and 2.5 µg/ml of amphotericin B) and cultured on 6-or 12-well culture plates (Corning; NE Schiphol-Rijk, The Netherlands). The complete culture medium and its individual components were determined free of detectable LPS by a turbidimetric Limulus ameobocyte lysate assay (Pyrotell-T; Associates of Cape Cod Inc., East Falmouth, MA, USA), with a sensitivity of 0.001 EU/ml, according to the manufacturer's instructions. The culture medium was renewed after 24 h, and again at 48 h, after which time experiments were initiated by the inclusion of agents in the culture medium and, in most instances, incubation for another 24 h, unless otherwise stated. Agents were dissolved in dimethylsulphoxide, the concentration of which was never greater than 0.20% (v/v), and which was always the same in control and experimental wells. After 3 days of culture, > 90% of the cells were surface mucous epithelial cells. 29, 30 Crystal violet assay Cells were grown in 12-well tissue culture plates. The culture medium was removed and 0.5 ml of crystal violet (0.4 g /100 ml) in 30% (v/v) methanol was added to each well for 20 min at room temperature. After removal of the stain, wells were washed 3 times with 1 ml of water and then allowed to dry. Stain was released from cells by incubation with agitation for 30 min at room temperature with 400 µl of sodium dodecyl sulphate (1 g/100 ml) in each well. Absorbance of 100 µl of the extracts was read at 570 nm on a plate reader.
Assay of caspase activity
Plates were placed on ice, the culture medium was removed and 1 ml of phosphate-buffered saline (PBS; 10 mM phosphate, 2.7 mM KCl, 137 mM NaCl), was added to each well. The cells were removed from the plate with a cellscraper, transferred to microfuge tubes, and were subjected to centrifugation for 20 s at 12,000 g. Pellets were rinsed with 1 ml of ice-cold PBS and then resuspended, by pipetting up and down 10 times, in 110 µl of homogenisation buffer: 100 mM HEPES buffer, 140 mM NaCl, 1 mM EDTA, (pH 7.4), containing 0.5 mM phenylmethylsulphonyl fluoride, 5 µg/ml aprotinin, 5 µg/ml pepstatin and 10 µg/ml leupeptin. Subsequently, extracts were frozen in liquid nitrogen and stored at -70°C. Assay homogenates were thawed and refrozen twice, before a final thaw and centrifugation at 12,000 g for 20 min at 4°C. Supernatant (25 µl) was incubated at 37°C with 175 µl of assay buffer consisting of 100 mM HEPES buffer (pH 7.4) and 20% (v/v) glycerol containing protease inhibitors at the same concentration as above, and the caspase substrates Ac-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin (Ac-DEVD-AMC, caspase 3-substrate), Ac-Leu-Glu-His-Asp-7-amido-4-methylcoumarin (Ac-LEHD-AMC, caspase 9 substrate) and Ac-Ileu-Glu-Thr-Asp-7-amido-4-methylcoumarin (Ac-IETD-AMC, caspase 8 substrate) at a final concentration of 15 µM. Formation of a fluorescent product was measured on a plate-reading spectrofluorimeter (Molecular Devices Ltd; Wokingham, UK) with excitation at 365 nm, emission at 467 nm and a cut-off filter at 435 nm. Protein was measured by using bicinchoninic acid reagent with bovine serum albumin as standard. 31 
Detection of apoptosis by staining with Hoechst 33258
Cells were removed from the culture plate by exposure to trypsin (0.5 g/l)/EDTA-Na 4 (0.2 g/l) and subjected to centrifugation for 20 s at 12,000 g. Cells were resuspended in 4% (w/v) paraformaldehyde in PBS for 10 min at room temperature, subjected to centrifugation at 12,000 g for 10 s, resuspended in ethanol: water (4:1), and stored at 4°C. Cells were transferred to glass slides by use of a Shandon cytocentrifuge, and nuclei were stained with 8 µg/ml of Hoechst 33258. Slides were coded, and the proportion of apoptotic nuclei was determined by counting using a fluorescent microscope, with apoptosis defined as the presence of two or more condensed bodies per nucleus. At least two fields, and a total of greater than 400 nuclei were counted for each well of the culture plate, and each treatment was performed in duplicate.
Incorporation of [ 3 H]-thymidine
[ 3 H]-Thymidine (2 µCi of specific activity 25 Ci/mmol) was added to each well of a 12-well culture plate. After 24 h, the medium was removed and the wells washed with 1 ml of ice-cold PBS. Cells were scraped into 0.75 ml of trichloroacetic acid (TCA; 10 g/100 ml), and left for 20 min on ice. The contents of the wells, and 0.5 ml of TCA used to rinse the wells, were transferred to microfuge tubes, centrifuged at 12,000 g for 1 min, the pellet washed with TCA, and finally dissolved in 0.2 ml NaOH (0.1 M) containing 1 g/100 ml sodium dodecyl sulphate at 37°C for 4 h. Incorporation of [ 3 H]-thymidine was determined by scintillation counting and expressed as a function of cellular protein.
Statistical analysis
Results are presented as mean ± SEM, with n equal to the number of separate cell cultures and, unless stated otherwise, were subjected to analysis of variance to remove variation between cell cultures, followed by either a Newman-Keuls' or a Dunnett's multiple comparison test. Data on the percentage of apoptotic cells were arcsine-transformed before analysis.
RESULTS
Effect of LPS on apoptosis
Exposure for 24 h to LPS from H. pylori NCTC 11637 increased caspase activity when the concentration was between 3 x 10 -6 and 3 x 10 -5 g/ml. The overall doseresponse curve was bell-shaped ( Fig. 1A) . LPS from E. coli O111:B4 gave a similarly shaped dose-response curve for enhancement of caspase 3-like activity, but activity peaked at a concentration of 10 -8 g/ml ( Fig. 1B) , three orders of magnitude lower than that found by using H. pylori LPS. After 24 h exposure to H. pylori LPS (10 -5 g/ml) there was no significant activation of either caspase 9-like or caspase 8-like activities, which were, respectively, 116 ± 17% and 95 ± 8% of control (n = 3).
Caspase 3-like, caspase 9-like and caspase 8-like activities (382 ± 13%, 182 ± 14%, and 146 ± 9% of control; n = 3) were all significantly increased (P < 0.05; t-test) after 6 h of exposure to H. pylori LPS (10 -5 g/ml). LPS from H. pylori produced a greater response in caspase 3-like activity and was active at a lower concentration after 6 h than after 24 h of exposure (compare Figs  1A and 2A ). The maximal response to E. coli LPS after 6 h was also greater than after 24 h, but there was no obvious shift in the lowest concentration at which E. coli LPS increased caspase activity (compare Figs 1B and 2B). Nevertheless, after 6 h of exposure, there was a difference of three orders of magnitude between the concentrations of LPS from E. coli and H. pylori at which activation of caspase 3-like activity peaked. When cells were exposed to H. pylori LPS for 6 h in a medium containing 0.1%, rather that 10% serum, no significant effect of LPS on caspase 3-like activity was detectable (10 -8 g/ml, 99 ± 4%; 10 -7 g/ml, 93 ± 2%; 10 -6 g/ml, 99 ± 8%; and 10 -5 g/ml, 86 ± 4% of control; n = 4).
Furthermore, the proportion of apoptotic cells after 24 h exposure to a range of concentrations of H. pylori LPS gave results (Fig. 3A,B ) consistent with the data obtained from measurement of caspase 3-like activity ( Figs 1A and 2 ).
LPS and DNA synthesis
[ 3 H]-Thymidine incorporation into cells over 24 h, in medium containing 10% fetal calf serum, was determined in the presence of various LPS concentrations (10 -9 to 10 -5 g/ml; 10-fold increments). With H. pylori LPS treatment ( n = 5), tritium incorporation (percentage of control) was 125 ± 10%, 109 ± 9%, 117 ± 10%, 128 ± 12%, and 119 ± 10%, respectively; although some elevation was suggested, no significant difference (P > 0.05) above control level on DNA synthesis was found by analysis of variance and Dunnett's test. Equivalent data with LPS from E. coli O111:B4 (n = 3; 109 ± 10%, 106 ± 5%, 107 ± 5%, 99 ± 10% and 93 ± 2%, respectively) 50 Durkin, Moran, Hanson again showed no significant effect (P > 0.05) of LPS concentration on DNA synthesis.
Effect of LPS on cell number
Incubation of gastric mucous epithelial cells for 24 h with H. pylori LPS appeared to lower cell number (determined by a crystal violet assay) only when the concentration was ≥ 10 -6 g/ml; and a significant reduction obtained with 10 -5 g/ml LPS (Fig. 4A) . By contrast, LPS from E. coli O111:B4 caused a reduction in cell number over the concentration range 10 -9 -10 -5 g/ml (Fig. 4B) . Similar results were obtained with LPS from E. coli AM1 (not shown). A concentration of 10 -5 g/ml H. pylori free lipid A was required to reduce crystal violet staining significantly (n = 4; 84.3 ± 3.7% of control; P < 0.05).
Effect of ibuprofen on caspase activity
Exposure to ibuprofen for 24 h produced a dose-related increase in caspase 3-like activity (Fig. 5 ). Addition of 10 -5 g/ml of H. pylori LPS further enhanced caspase activity (P < 0.001, analysis of variance). Caspase activities (pmol/min/mg protein) in cells exposed to H. pylori LPS together with either 250 µM or 500 µM ibuprofen (filled bars Fig. 5 ; 420 ± 54 and 625 ± 68, respectively) were significantly different (P < 0.05 and P < 0.01, paired t-test) from the cumulative caspase activities calculated from addition of the separate effects of ibuprofen and H. pylori LPS when used alone (330 ± 62 and 327 ± 67, respectively). This difference indicates that a synergistic interaction occurred between H. pylori LPS and ibuprofen, when present together, to enhance caspase 3-like activity.
The onset of apoptosis in response to ibuprofen was much slower than with LPS (see above). Thus, after 6 h of exposure to 250 µM ibuprofen (n = 7), caspase 3-like activity was only 119 ± 4% of control, compared with the significantly higher (P < 0.001) 212 ± 10% (n = 10) after 24 h. Caspase 9-like activity was 123 ± 10% after 6 h, but 158 ± 5% of control after 24 h (both n = 3), the latter being a significant activation (P < 0.001, t-test). On the has been normalised to that obtained with control cells (233 ± 14 and 269 ± 57 pmol/min/mg protein, respectively). In each panel, the left-hand clear bar represents results for cells exposed to neither ibuprofen nor LPS. The adjacent bar represents results for ibuprofen alone and the remaining bars data for ibuprofen in the presence of varying LPS concentrations. Data were subjected to analysis of variance followed by a Newman-Keuls' test. For all panels, all results were significantly different (P < 0.05) from the control (no additions). *P < 0.05; **P < 0.01; ***P < 0.001 for difference from ibuprofen alone. other hand, caspase 8-like activity was 102 ± 3% and 138 ± 16%, respectively, neither of which represented a significant activation (n = 3).
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Effect of LPS on caspase activity and cell loss in the presence of 250 µM ibuprofen
The effect of concentration and source of LPS on caspase activity was investigated in the presence of a near-maximally effective concentration of ibuprofen (250 µM). LPS from E. coli O111:B4, over the range 10 -9 -10 -5 g/ml, produced a dose-related reduction in cell number greater than that produced by ibuprofen alone (Fig. 6A) . This enhancement of cell loss was reflected in an increased caspase 3-like activity above that produced by ibuprofen alone (Fig. 6C ). H. pylori LPS (at 10 -5 , 10 -4 and 3 x 10 -4 g/ml) produced significant cell loss greater than that produced by ibuprofen alone (Fig. 6B) . Likewise, caspase-3-like activity was higher with H. pylori LPS (at 3 x 10 -6 , 10 -5 and 3 x 10 -5 g/ml) than that produced with only ibuprofen (Fig. 6D) .
Effect of LPS on the proportion of apoptotic cells in the presence of ibuprofen
The proportion of apoptotic cells was increased by exposure to ibuprofen and this proportion was further increased upon exposure to H. pylori LPS at 10 -6 g/ml and 10 -5 g/ml ( Fig. 7) . At 10 -5 g/ml the experimental response to a combination of LPS and ibuprofen (14 ± 0.6%) was significantly greater (P < 0.05; t-test) than that calculated by adding the separate effects of ibuprofen and H. pylori LPS (taken from Fig. 3 ) when used alone (8.9 ± 0.6%), thus indicating a synergistic interaction between LPS and ibuprofen.
DISCUSSION
The main findings of the present study are that: (i) contrary to a previous report, 10 LPS from the H. pylori type strain (NCTC 11637) which is virulent (CagA-positive, VacA-positive) is clearly a less potent inducer of cell loss and apoptosis in gastric mucous cells than E. coli LPS; (ii) the combination of LPS with ibuprofen produced a loss of gastric mucous cells additional to that induced by ibuprofen alone; and (iii) apoptosis made a contribution to this effect.
Net cell number is determined by the balance between cell gain through proliferation and cell loss through necrosis and apoptosis. Despite previous reports that H. pylori 32 and H. pylori 9 LPS can increase DNA synthesis in, respectively, the cell lines AGS and HMO2, and in primary cultures of rat enterochromaffin-like cells in the presence of gastrin, no significant effect of high purity LPS from either E. coli or H. pylori was found using guinea-pig gastric mucous cells in the present study. This may reflect differences in the purity of the LPS preparations employed, and that other LPS-independent mechanisms of H. pylori can contribute to changes in DNA synthesis in gastric cells. Generally, there was a good correlation between cell loss and increases in caspase 3-like activity or the proportion of apoptotic cells. An exception was the effect of concentration of E. coli LPS on caspase activation where the dose-response curve is bell-shaped, but that for cell loss is not (Figs 1B  and 4B) . This difference may be explained by caspase activity reflecting apoptotic activity at the moment the cells are harvested, whereas net cell loss reflects events over the previous 24 h. Alternatively, high concentrations of E. coli LPS may cause cell loss through necrosis. Nevertheless, with H. pylori LPS a reasonable interpretation is that changes in apoptosis caused cell loss.
Apoptotic activity was measured only in attached cells. For epithelial cells, detachment induces apoptosis by the process of anoikis. 33 The consequence is that in control incubations most detached cells are undergoing apoptosis giving a high basal activity 20 against which to measure the effect of agents. Furthermore apoptosis in detached cells could be secondary to a primary effect of the agent in inducing cell detachment. Finally, inclusion Lipopolysaccharide and apoptosis in gastric cells 53 Fig. 7 . Effect of H. pylori LPS on the proportion of apoptotic cells after 24 h in the presence of 250 µM ibuprofen. Data are mean ± SEM from four cultures and were subjected to analysis of variance followed by a Newman-Keuls' test. The left-hand clear bar represents results for cells exposed to neither ibuprofen nor LPS. The adjacent bar represents results for ibuprofen alone and the remaining bars data for ibuprofen in the presence of varying LPS concentrations. All results were significantly different (P < 0.05) from the control (no additions). *P < 0.05; ***P < 0.001 for difference from ibuprofen alone. of previously detached cells blurs the determination of the time-dependency of apoptotic activity.
The lowest concentration of LPS from either E. coli O111:B4, or the clinical isolate E. coli AM1, that induced cell loss and apoptosis relative to the control after 24 h was 10 -9 g/ml in agreement with data of Kawahara et al. 10 However, in contrast, significant cell loss and apoptosis only occurred after 24 h exposure to LPS, or lipid A, from H. pylori at concentrations 1000-10,000-fold higher. This difference in LPS potency is similar to that of previous comparative studies between H. pylori and enterobacterial LPSs on mitogenicity of mouse spleen cells and pyrogenicity in rabbits, 13 on production of procoagulant activity by human blood mononuclear leukocytes, 14 and on interleukin-8 production by neutrophils, as well as induction of other cytokines from the macrophage-monocyte cell lineage. [15] [16] [17] In the gastric cell line MKN 17, synthetic lipid A from E. coli at a concentration of 0.05 µg/ml produced a greater stimulation of interleukin 8 production than that of 500 µg/ml of synthetic lipid A from H. pylori. 34 On the reasonable assumption of a similar maximal response to both agents, an at least 10,000-fold difference in potency would seem to exist between purified lipid A from E. coli and H. pylori for their effects on MKN cells, which is not too different from the 25,000fold difference in endotoxin activity. 34 Nevertheless, Kawahara et al. 10 obtained a major stimulation of apoptosis in guinea-pig gastric mucosal cells with 10 -9 -10 -8 g/ml LPS extracted from the same H. pylori strain (NCTC 11637) as used here. A 6-h incubation in a medium containing 0.1% serum was used in the former study, but in the present study under the same conditions, no activation of caspase 3-like activity was found by H. pylori LPS (10 -9 -10 -5 g/ml). Moreover, in the presence of 10% serum for 6 h, the lowest concentration of H. pylori LPS that increased caspase 3-like activity was 10 -7 g/ml, which contrasts with the significant activation of caspase 3-like activity by 10 -9 g/ml of E. coli LPS under the same circumstances. Of particular relevance, the difference may reside in the nature or purity of the LPS tested. Kawahara et al. 10 used a similar LPS extraction and purification procedure as that used in this study (which we had formulated previously 27 ), except for preliminary treatment of bacteria with pronase E before LPS extraction. Previous studies have indicated that the pronase pretreatment disrupts protein-LPS interactions in the bacterial cell wall, thereby aiding phenol-water extraction of LPS, and producing LPS in good yields and of high purity, but not influencing LPS nature. 27 A highly potent activation of TLR-4 by H. pylori LPS as described by Kawahara et al. 10 does not entirely accord with the organism's ability to evade removal by the host's immune system, and the chronic nature of this infection. Moreover, more recent studies by Mandell et al. 35 have shown lower TLR-4 binding by a number of H. pylori LPSs than by that of E. coli. Also, it is unclear how a low concentration of H. pylori LPS could stimulate apoptosis in an environment (≤ 0.1% serum) where the concentrations of LPS-binding protein (LBP) and soluble CD14, that are required for interaction with LPS and Toll-like receptors, are likely to be very low, 36 especially as H. pylori LPS binds inefficiently to LBP and is poorly transferred to soluble CD14. 37 The present findings of low potency of H. pylori LPS on gastric cells accord with recent data that a concentration of H. pylori LPS of greater than 10 -5 g/ml is required to stimulate pepsinogen release from gastric cells, 38 and that LPS from E. coli, but not H. pylori, stimulated cyclooxygenase-2 activity in gastric cell lines. 39 A concentration of ibuprofen of 250 µM was chosen to assess interactions with LPS, because this concentration produces a substantial and near-maximal increase in apoptotic activity, 21 without the necrosis found at higher concentrations of NSAIDs. 22 In the presence of 250 µM ibuprofen, LPS from both E. coli and H. pylori produced additional cell loss, which was associated with enhanced apoptosis. LPS is considered to activate TLR-4 leading, as found in this study, to activation of caspase 8, and secondary activation of caspase 9; 5,10 an example of a receptor-mediated pathway of apoptosis. Ibuprofen acts via induction of an endoplasmic reticulum stress response with increased expression of the pro-apoptotic transcription factor CHOP and activation of caspases 12, 9 and 3. 40 In the present work, ibuprofen produced a slow activation of apoptosis with increases in caspase 3 and caspase 9 activities after 24 h which is consistent with changes in gene expression, and protein synthesis, 20 leading to activation of apoptosis through the above pathway. Thus, a reasonable explanation of the observed positive interaction, which in some instances was synergistic, between ibuprofen and LPS is that while LPS acts by the receptor-mediated pathway, ibuprofen affects a separate pathway involving an endoplasmic reticulum stress response. The interaction of LPS and ibuprofen may be limited by the apparent decline in LPS activation of caspase activity between 6 and 24 h, and with sustained exposure to LPS appearing to induce some form of desensitization of the response mediated by TLR-4. Thus, as in intestinal epithelial cells, continuing presence of LPS may result in a state of reduced responsiveness. 41 The relatively low potency of H. pylori LPS reported here does not necessarily preclude a role for H. pylori LPS in pathology such as the production of a chronic low-grade gastritis, particularly since the effective concentration of LPS on the cell surface in vivo is uncertain. The present results suggest that such a contribution could occur in patients infected with H. pylori but also taking NSAIDs. In human patients, the gastric apoptotic index was greater in patients who were H. pylori-positive and had received NSAIDs for 8 weeks than in those receiving NSAIDs and in whom H. pylori had been eradicated. 18 Both individual studies 24 and a recent metaanalysis 25 have suggested that H. pylori and NSAIDs may interact positively to cause peptic ulcer disease. The present results indicate that a component of that interaction may involve a positive interplay between H. pylori LPS and NSAIDs to enhance apoptosis. Use of adenocarcinoma cell lines and live H. pylori to address this issue further may not be successful since Kato III and AGS cells have been deduced not to express TLR-4. 42 On the other hand, H. pylori does not attach to guineapig gastric mucous cells; 30 thus, use of whole bacteria alone in this system would not completely mimic natural infection, whereas LPS or outer membrane-derived material might be more relevant.
CONCLUSIONS
Our results show that LPS and the NSAID, ibuprofen, combine to promote cell loss and apoptosis in guinea-pig gastric mucous cells. Higher concentrations of LPS from H. pylori than from E. coli were required, consistent with the previously described lower immunological activities of H. pylori LPS and lipid A. 17 Importantly, the results suggest that, in the gastric environment with extensive and chronic infection by H. pylori, the interaction of LPS with NSAIDs to cause apoptosis could contribute to pathogenesis and promote pathology development.
